Source link : https://newshealth.biz/health-news/second-biologic-might-improve-tolerability-of-multi-food-allergy-immunotherapy/
(MedPage Today) — PHILADELPHIA — For multi-allergen oral immunotherapy (mOIT) patients, adding dupilumab (Dupixent) after omalizumab (Xolair) showed promise for cutting the gastrointestinal adverse events (AE) of ongoing mOIT, although perhaps… Source link : https://www.medpagetoday.com/meetingcoverage/aaaai/120098 Author : Publish date : 2026-02-28 21:37:00 Copyright for syndicated content belongs to the linked Source.
The post Second Biologic Might Improve Tolerability of Multi-Food Allergy Immunotherapy first appeared on News Health.
—-
Author : News Health
Publish date : 2026-02-28 21:37:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8